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Abstract
Background: Malignant melanoma has become an increasingly prevalent problem in the United
States. The earlier a skin cancer is identified, the better the outcome. There are conflicting
recommendations about screening for skin cancer but in general identifying high risk patients is
important and it is not being achieved in primary care.
Purpose: The purpose of this study is to evaluate use of the SAMScore Questionnaire to
determine high risk patients at adult annual visits.
Methods: This was a multi-phased study with a quasi-experimental design that took take place at
a family and community primary care clinic in central Kentucky. Baseline assessment of skin
cancer screening frequency and education during annual exams was obtained with a medical
record review. Providers were then educated on the use of the SAMScore and asked to start
using with adult patients during annual exams. After a period of 3 weeks, a post-intervention
review of medical records was completed to assess provider documentation related to skin cancer
screening risk using SAMScore and education. Inclusion criteria involved patients aged 18-64
years old of all genders, races, and ethnicities.
Results: The phase one chart audit included 30 patient charts and the phase three chart audit
included 48 patient charts. There was a significant increase in screening completion from pre- to
post-intervention. None of the participants were screened pre-intervention, and more than half
(56%) were screened post (p<.001). Of the 27 patients screened, 14 (52%) were documented as
being at high risk and of those patients, (100%) received education on skin protection.
Conclusion: One hundred percent of the patients identified as high risk at this clinic were
educated on skin protection, but only about half of the eligible patients were indeed screened.
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Further research should be done to address barriers to screening and continued efforts should be
made to ensure our primary care providers are identifying those at high risk for skin cancer.
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Background and Significance
Problem Statement

Malignant melanoma has become an increasingly prevalent problem in the United States
in the 21st century (CDC, 2015). According to the CDC, rates of malignant melanoma doubled
from 1982 to 2011. Melanoma is the deadliest form of skin cancer and claims about 9,000 lives
each year (CDC, 2015). Prevention and early detection are key to decreasing rates of malignant
melanoma in the United States and decreasing the number of deaths associated with it each year.
Primary care providers need to identify patients who are at higher risk for developing malignant
melanoma (fair skin, first degree relatives with Melanoma, etc.) to provide them with the best
care. Currently, there is a lack of skin cancer risk screenings completed by primary care
providers at adult annual exams.

Context, Scope, and Consequences of the Problem

Malignant melanoma is a form of skin cancer that can travel to other parts of the body
and cause high rates of death. Ninety percent of all melanomas are caused by exposure to
ultraviolet light radiation, which can be due to excessive sun exposure or the use of indoor
tanning facilities (CDC, 2015). This radiation causes mutations to occur at the cellular level
which can form cancerous growths or tumors. Along with exposure to UV light, other risk
factors include having fair skin, having numerous moles, and a family history of melanoma (Skin
Cancer Foundation, 2019).
It is estimated that there will be 30,370 new cases of Melanoma in Kentucky in 2022,
with an estimated death rate of 9,740 (American Cancer Society, 2022). The annual cost of
treating skin cancers in the U.S. is estimated at $8.1 billion (AAD, 2021). Survival rates of
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malignant melanoma decrease from 99%, when identified early in stage 1 or 2, to 63% when it
has spread to the lymph nodes in stage 3, and to 20% survival rates when it metastasizes to other
organs in stage 4 (Skin Cancer Foundation, 2019). The earlier a skin cancer is identified, the
better the outcome. Ideally, primary care providers would routinely screen patients at annual
exams to determine their risk. Providers need to identify patients who are at higher risk for
developing malignant melanoma to provide them with the best care.

Current Evidence-Based Recommendations
Three main organizations have different recommendations regarding skin cancer
screening. The Skin Cancer Foundation recommends using sunscreen with SPF 15 or higher,
avoiding the use of tanning beds or getting sun burned, examining your skin head-to-toe every
month, and having a professional skin examination every year (Skin Cancer Foundation, 2019).
The USPSTF states that current evidence is insufficient to assess the risks versus benefits of
annual skin exams in asymptomatic patients, but this does not address those that are considered
to be at high risk (HHS, 2016). According to Memorial Sloan Kettering Cancer Center (2022),
although it is not recommended for asymptomatic patients to be screened annually, they do
recommend that individuals identified as high risk (a family history of melanoma in two or more
blood relatives, the presence of multiple atypical moles, the presence of numerous actinic
keratoses, etc.) be evaluated once a year for a head-to-toe skin cancer assessment. Further, the
USPSTF does recommend behavioral counseling for skin protective behaviors for specific
populations at higher risk (HHS, 2016). The USPSTF states that “behavioral counseling” is
aimed at reducing ultraviolet radiation exposure. Sun-protective behaviors the patient should be
counseled on include the use of a broad-spectrum sunscreen with a sun protection factor ≥15,
wearing hats or other shade-protective clothing, avoiding the outdoors during midday hours (10
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a.m. to 3 p.m.), and avoiding the use of indoor tanning. They state that effective counseling
interventions can be generally of low intensity and accomplished within a primary care visit
(USPSTF, 2018). Although this is their recommendation, a survey found that only 48% of
primary care providers (PCPs) regularly educate patients on skin protection regardless of patient
risk (Holman et al, 2019). This illustrates the disconnect between current practice and specific
recommendations for patients at high risk, as well as providing education on skin protection.
The SAMScore Questionnaire (Quéreux et al., 2011) is an evidence-based tool that lists
seven risk factors for the patient to select as they apply to them (see Appendix 1). This tool is
used to identify patients that are at higher risk for developing Melanoma. Providers are
responsible for evaluating the patients risk based on their answers on the questionnaire. A patient
is considered at elevated risk for melanoma if at least one of these three criteria is verified:
Presence of at least 3 risk factors (phototype I or ii, freckling tendency, number of naevi >20 on
both arms, severe sunburn during childhood or teenage years, life in a country of low latitude, a
history of previous melanoma, a history of melanoma in a first-degree relative), a subject under
60 years of age and a number of melanocytic naevi >20 on both arms, and a subject 60 years old
or older with a freckling tendency. This tool can be used to identify patients at high risk for skin
cancer and help bridge this gap between recommendations and actual practice for those at high
risk for developing skin cancer.

Purpose/Objectives

The purpose of this study is the evaluate use of the SAMScore Questionnaire to determine high
risk patients at adult annual visits. With the implementation of this screening tool among primary
care providers at primary care annual exams, the objectives of this study are to:
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1. Evaluate the number of skin cancer risk screenings and actual risk charted by providers at
annual exams before and after implementation of the screening tool
2. Evaluate skin protection education offered to patients after screening

Theoretical Framework
Lewin’s Theory of Change was used to guide the change implemented in this project.
The theory was developed by Kurt Lewin in 1947 and involves three steps: unfreezing, changing,
and refreezing. According to Lewin, the process of change involves developing a perception that
a change is needed, then directing interventions toward the new desired behavior and then
making that behavior the new norm. The first step is unfreezing. This is the process which
involves developing methods that make it possible for people to understand the need for change
or new behaviors. The next step is the change step, which is also called the “movement” step.
This involves a process of change in thoughts, feelings, and behaviors, that is aimed at reaching a
certain goal. Finally, the refreezing stage is instituting the change as the new standard behavior.
so that it now becomes the “standard operating procedure” (Lewin, 1947). During the first stage,
unfreeze, the current process for screening patients for skin cancer risk was evaluated at the
clinic, and the SAMScore Questionnaire was appraised to improve this process. During the
movement stage, the SAMScore Questionnaire at annual exams was implemented through one
PDSA cycle. The refreezing stage comes after there has been a successful process to change.
Review of Literature
A literature review was conducted to determine the effectiveness of risk assessments in
primary care to identify patients at higher risk for skin cancer and the evidence surrounding skin
protection education. Specifically, the question guiding the review is: “Does providing
SAMScore Questionnaires to adult patients at annual exams increase provider documentation of
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skin cancer risk and skin protection education provided to those at high risk for skin cancer?”
This literature search was conducted using CINAHL and PubMed, and included articles
published from 2000-2020. The list of search terms for population used in this literature search
included: “adult patients OR adult population,” and “primary care OR primary care providers,”
“malignant melanoma OR skin cancer AND risk,” “skin cancer AND risk screening,” “skin
cancer screening OR skin exam OR skin assessment,” “skin protection education OR skin cancer
prevention education AND primary care,” and “skin cancer risk AND tool,” “skin cancer risk
AND questionnaire.” Inclusion criteria involved studies that had free full text options, were
published in English, and were peer reviewed primary studies. The review excluded articles that
were in a language other than English, studies from unreliable sources or studies that did not
directly relate to skin cancer in the primary care setting. Nineteen articles were found that meet
the inclusion and exclusion criteria and 13 were chosen to be analyzed based on quality of
evidence and themes.

Review, Analysis, and Synthesis of Evidence
Based on the 13 studies gathered involving skin cancer screening in primary care, three
themes were revealed: low rates of skin cancer screenings, the importance of skin protection
education and the discussion involving risk assessment tools.
The disconnect between evidence and practice of screening rates is illustrated by a study
which found that skin cancer prevention and screening activities in the primary care setting were
much less frequently occurring than other cancer screening and prevention activities. Skin
examination was reported at only 15.8% of all visits (Oliveria et al, 2011). This evidence was
further maintained by a National Health Interview Survey (NHIS) that found that 16% of men
and 13% of women reported having a skin examination in the past year (Coups et al, 2010). It is
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interesting to note that previous NHISs reported the percentage of the U.S. adult population that
reported having a skin examination conducted by a provider was 20.6% in 1992, 20.9% in 1998,
and 14.5% in 2000 (Saraiya et al, 2004). The figures indicate that skin cancer screening rates
have been consistently low and are decreasing over the last few decades.
The USPSTF recommends behavioral counseling for skin protective behaviors for
specific populations at higher risk (HHS, 2016), but in 2019 a survey found that only about
48.5% of all providers reported regularly counseling on sun protection regardless of patient risk
level (Holman et al, 2019). A systematic evidence review for USPSTF found that the current
fair-to-good evidence base suggests that behavioral interventions can increase sun protection
behavior in both pediatric and adult populations (Henrikson et al, 2018). A study from 2018
concluded that to have sufficient primary prevention of skin cancer, it is essential that patients
are provided counseling and education on protective behaviors (Vasicek, Szpunar, & ManzDulac, 2018). Another study evaluated the impact that skin protection counseling had on
patients’ knowledge base and found that although individuals were able to identify skin cancer as
an area of concern, few were able to identify ways to prevent skin cancer or the risks for skin
cancer before being provided the related education (Nickasch et al, 2020). As a result, these
authors claimed, as this study made evident, that simple skin cancer counseling can provide great
benefit in increasing knowledge among those educated.
The third theme found during this review of literature revolved around risk screening
tools for developing skin cancer. There is not much research available on many of the screening
tools discovered throughout this review. One tool identified was The Melanoma Risk
Assessment Tool (Fears et al, 2006) which is a risk calculator which was developed to estimate a
patient's absolute risk of developing invasive melanoma. The absolute risk identified with this
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tool estimates the likelihood that a person will develop melanoma over the next 5 years.
According to the developers of this tool, it has not been tested in large populations and thus it has
not been "validated" (Оshyvalova, 2019). The SAMScore Questionnaire is a validated screening
tool that provides a skin cancer risk assessment that categorizes patients as having normal or
high risk and this risk stratification can be used to make recommendations and tailor education
(Quéreux et al., 2012). It is made up of seven questions and is completed by the patients
themselves. The provider then evaluates their results and determines if the patient is of normal or
high risk. The efficiency of the SAMScore risk assessment tool as a targeted screening for highrisk individuals has been documented through many studies (Quéreux et al., 2012; Davies et al.,
2015; Rat et al., 2014). The efficiency assessed was equal to 11.54 (P=0.0016). This means that
it is necessary to screen 11 times fewer patients when using the SAMScore Questionnaire than
with a nontargeted screening tool (Quéreux et al., 2012), and thus it can help identify those who
may need more focus on skin cancer prevention (Davies et a., 2015). The combination of use of
the SAMScore and general practitioner examination and counseling during consultations is an
efficient way to promote patient behaviors that may reduce melanoma risk. Further, a study from
2014 found that the combination of SAMScore, skin assessments and education was the most
efficient way to promote patient behaviors that may reduce melanoma risk (Rat et al., 2014).

Summary of the Evidence
This literature review shed light on the current practices surrounding skin cancer
screening and skin protection education/ behavioral counseling in primary care. Evidence
supports that there is a disconnect between recommendations for skin cancer screening and
current practice.
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There is limited research to support specific recommendations for skin cancer risk
assessment, frequency of skin cancer risk screening in primary care and risk assessment tools.
The available research supports the recommendation to provide skin protection education for
patients to prevent skin cancer, especially for those at high risk. These gaps could be addressed
by the implementation of the SAMScore skin cancer screening tool at adult annual exams by
providing a tool to help guide primary care providers in evaluating risk assessments on their
patients, as well as identifying those patients that need education on skin protection.

Methods
Design
This was a multi-phased study with a quasi-experimental design aimed at gathering
information on the outcomes of using the SAMScore Questionnaire to identify high risk adult
patients at adult annual visits in a primary care setting. This study consisted of three different
phases: There was a baseline chart audit completed. Primary care providers that agreed to
participate were then educated on the SAMScore Questionnaire and asked to include it in their
standard workflow at annual visits. Finally, a post-intervention chart audit was completed to
determine the effect the tool had on skin cancer risk assessments being completed.

Setting
Agency Description
This project took take place at a family and community primary care clinic in central
Kentucky. The office provides care to a racially and economically diverse population of all ages.
There are six providers at this office, two APRNs, and four MDs, all of which specialize in
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family medicine. Prior to implementation of this study, skin cancer risk screening was not a part
of the providers’ standard workflow at annual patient exams.

Agency Mission Statement
This office is part of a large university-based health system, whose mission statement is,
“Through our DIReCT values, in support of our mission and commitment to patient care,
education and research, our 2025 vision will inspire us toward an achievable future.” Their
mission is centered around five values. The first is diversity; they state that their employees
should foster an inclusive and people-centered environment. Next is innovation; their employees
are encouraged to strive to consistently seek better ways to perform at work, find creative
solutions, and drive positive change. Third is respect, “We value our patients and families, our
community, our co-workers, ourselves, and the resources entrusted to us”. The fourth value is
compassion. This value supports empathy for the needs, thoughts and feelings of fellow
employees and patients. Finally, teamwork; this has a focus on “cultivating and maintaining
meaningful relationships to create positive outcomes” (UKHealthcare, 2020). This project fits
their mission, as it was designed with a focus on innovation, teamwork, compassion with the
patients’ best interest in mind with a goal of identifying patients at high risk for skin cancer.

Stakeholders
The key stakeholders in this project include the office’s primary care providers who
implemented the use of the SAMScore Questionnaire and provide subsequent patient care based
on results. Other staff such as medical assistants that were part of the patient care at the visits are
also key stakeholders, as well as the patients who filled out the questionnaire and finally the
office’s administrators who approved the project.
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Facilitators and Barriers to Implementation
There are many facilitators to implementing this project, specifically at this location. The
main facilitator is the large number of patients seen per day at this office. This allows for a
higher number of annual exam visits and thus, possible study participants. Another facilitator is
that the SAMScore Questionnaire is short, with only seven questions and takes less than 5
minutes for the patient to complete. This is less time consuming than some other screening tools,
making it more convenient for the patient. Further, because of the simplicity of the questionnaire,
only a small amount of education is needed for providers to understand and interpret the results.
Because the patient completes the questionnaire, time is saved for the provider since they do not
have to be involved with asking the questions and filling out the form for the patient. The most
important facilitator was that the primary care providers that participated in this study were very
receptive to the education provided to them and voiced how motivated they are to providing their
patients with the best care that they can.
Although there are many facilitators, there are also some barriers to implementation. One
barrier is introducing something new to an already established routine. Change is something that
is sometimes not welcomed, so implementing a new questionnaire at all annual exams could
receive some resistance from the primary care providers. Another barrier could be the extra time
and effort required of the provider to complete the interpretation of the questionnaire filled out
by the patient and the subsequent patient care involved based on those results. Providers already
have many tasks to complete at annual visits, adding another thing to their list may receive some
resistance. By using the PDSA Model to address these barriers, providing proper education to the
providers on the short time it takes for the patient to complete the survey, as well as the purpose
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and importance of the screening tool, it may decrease their hesitancy to implement the tool into
their workflow and encourage them to embrace the change.

Sample
The study population for the first phase of this project included 30 patient charts.
Inclusion criteria involved patients aged 18-64 years old of all genders, races and ethnicities who
had an adult annual wellness exam scheduled in December of 2021. Exclusion criteria involved
that outside of the age range and those previously diagnosed with Melanoma.
Phase two focused on the clinics primary care providers. There are four MDs and two
APRNs with varying degrees of experience, both male and female, varying ethnicities, and ages.
Inclusion criteria involved being a primary care provider and the ability to agree to participate in
the study and provide informed consent. One APRN and one MD participated in the study.
The third phase of the project included 48 patient charts to evaluate screening practices
after implementation. Inclusion criteria involved patients aged 18-64 years old of all races and
ethnicities who had an adult annual wellness exam scheduled in January of 2022. Exclusion
criteria involved those outside the age range and those previously diagnosed with Melanoma.

Procedure
IRB Submission Process
A proposal was submitted for expedited review to the University of Kentucky’s
Institutional Review Board (IRB) for this project and was approved on October 16, 2021.
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Evidence-based Intervention
The Plan, Do, Study, Act (PDSA) model for improvement is the improvement framework
used to guide the implementation of the SAMScore skin cancer screening tool at adult annual
exams (Deming, 1993). This is an improvement framework that is made up of many continuous
cycles of evaluation, change/acceptance, and re-implementation until it is determined that the
goal has been reached, and it is ready to be implemented systemwide.

Plan
The first of the four stages in this model was the “Plan” stage; this involves identifying a
goal or purpose, formulating a theory, and defining success metrics and putting a plan into
action. For this study, planning included auditing patient charts to get a baseline assessment of
how often skin cancer risk screenings are being documented. It also included meeting with
providers to determine participants for the study and collecting signed consent forms. Providers
were educated by the PI face-to-face at the clinic. Primary care providers were educated on what
the SAMScore Questionnaire is, how it is used, how it is interpreted and the aims of the project;
see Appendix 2 for an outline of the education provided to the PCPs. The education took around
15 minutes to provide. A date was then selected for implementation of the plan.

Do
The next stage is the “Do” phase, or implementation phase. The questionnaire was
provided to the patient to fill out at the beginning of their annual appointment and providers
evaluated and documented their risk for skin cancer and provided appropriate education based on
their risk. This was then documented by the providers.
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Study
The third phase, “Study”, is where outcomes are monitored to test the validity of the plan
for signs of progress and success, or problems and areas for improvement. This was the phase in
which charts were re-audited.

Act
Based on the results, the “Act” phase determined if the use of the SAMScore
Questionnaire at annual exams would be modified, accepted, or rejected. The original plan for
the study was to complete multiple PDSA cycles, but due to time constraints, only one full cycle
was possible. The next cycle would have included a survey and focus group with providers to
identify perceived barriers and explore strategies to address those barriers.

Measures and Instruments
The measures for this study included whether providers documented that their patients
were screened using the SAMScore Questionnaire, the patient risk based on screening and
whether they provided education on skin protection at their annual exam. The instruments that
were used included the SAMScore Questionnaire and the audit tool (see Appendix 1). The
efficiency of the SAMScore risk assessment tool as a targeted screening for high-risk individuals
has been documented through many studies (Quéreux et al., 2012) and thus help identify those
who may need more focus on skin cancer prevention and/or early detection (Davies et a., 2015).
This tool has a reported sensitivity of 63.2% and specificity of 68.8% (Quéreux et al., 2011). As
mentioned in the literature review, it is necessary to screen 11 times fewer patients when using
the SAMScore Questionnaire than with a nontargeted screening (Quéreux et al., 2012).
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Data Collection and Analysis
In phase one, medical records of 30 patients were evaluated to determine the patients age,
gender, race, whether a skin cancer screening was completed, what their risk was and if
education was provided using a chart audit tool (see Appendix 3). Every third chart that fit the
inclusion criteria was included in the review. The charts were manually reviewed by the PI. After
implementation in phase three, the same review of medical records was completed with 48 charts
to gather data on the patients that completed the SAMScore Questionnaire. All applicable charts
were included in the phase three review. Again, the charts were manually reviewed by the PI.
Study variables were summarized using means and standard deviations or frequency
distributions, as appropriate. Differences in demographic characteristics and screening practices
were evaluated using the two-sample t-test, chi-square test of association or Fisher’s Exact test.
Significance was set at p < .05. All analyses were conducted in SPSS, version 25 with an alpha
of .05.

Results
The results from this study include data from the pre-intervention period (n=30) and postintervention (n=48) chart review. The mean sample age pre-intervention (39.5) was very similar
to the sample age post-intervention (41.1; p=0.62; see Table 1). Of the 30 patient charts audited
in the pre-intervention phase, about two thirds (73.3%; n=22) were female, and about one third
(26.7%; n=8; see Table 1) were male. Post-intervention, of the 48 patient charts audited, females
(58.3%; n=28), and males (41.7%; n=20) were more equally distributed, but the difference was
not statistically significant (p=0.329; see Table 1). When looking at the patients’ race/ethnicity of
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charts audited pre-intervention and post-intervention, the majority of both samples were
Caucasian, but there was no statistically significant difference (p=0.99; see Table 1).
There was a significant increase in skin cancer screening completion from pre- to postintervention. None of the participants were screened pre-intervention, and more than half (56%)
were screened post (p<.001; see Table 2). Of the 27 patients screened, 14 (52%) were
documented as being at high risk and of those patients, all 14 of those patients (100%) received
education on skin protection. Among those not documented as high risk (n= 34), 13 (38%)
received education on skin protection. Only about half of the patients at normal risk were
provided education and all patients at high risk were provided education (see Table 3). There was
no statistically significant difference in rates of screening among those patients who were
screened across age, gender, or race/ethnicity (see Table 4). The results from this study show that
the use of the SAMScore Questionnaire increased documented skin cancer risk screenings for
patients seen for annual visits, and increased skin protection education for all patients, especially
those at high risk.

Discussion
The results from this project provide insight into several aspects of the topic of skin
cancer risk screening among the providers at the primary care clinic evaluated in this study. First,
there is a need for increased skin cancer risk screenings for all patients, and a need for increased
skin cancer prevention education provided to patients at high risk. Primary care providers should
be following the MSKCC recommendation. They should be identifying patients at high risk for
developing skin cancer using the SAMScore Questionnaire and those patients at high risk should
receive an annual skin assessment. At this clinic, the rate of skin cancer risk screening went from
0% to 58%. Based on these results, it seems that the PCPs that participated in this project saw the
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value in using the SAMScore Questionnaire to identify their high-risk patients and provide them
with skin protection education. With that said, even though there was an increase in screening
rates, there is still room for improvement.
The USPSTF recommends behavioral counseling for skin protective behaviors for
specific populations at higher risk (HHS, 2016), but does not recommend skin cancer risk
assessment. Without a valid and reliable skin cancer risk assessment, it is likely that many highrisk patients will be missed. Therefore, at minimum, all patients should receive a skin cancer risk
assessment once a year. Once a patient is identified as high risk, they can then be provided with
evidence-based recommendation such as targeted educated, completion of or referral head to toe
skin assessment. Further investigation into why there was not 100% documentation rate of risk
screening at annual visits is warranted. Providing a survey to providers at this clinic to identify
barriers and facilitators of screening, then conducting a focus group to discuss the facilitators and
barriers and brainstorm ideas for improvement would likely help identify what needs to be
adjusted prior to the next cycle of implementation, with the goal of achieving 100% skin cancer
screening rates using the SAMScore Questionnaire.

Practice Recommendations
This study revealed many possibilities for primary care providers regarding skin cancer
risk screening. As mentioned above, PCPs should be informed of all the screening guidelines and
could be guided to the MSKCC recommendation because it specifically addresses patients at
high risk and provides a guideline that has a proactive approach to identifying skin cancer early
in these patients. First, they should identify patients at high risk for developing skin cancer using
the SAMScore Questionnaire and then they should complete or refer annual skin assessments on
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those patients at high risk. From here, PCPs may need to be further educated on current
recommendations, available risk screening tools, as well as the importance of doing so.
Educating other staff, such as nursing assistants, on the importance of the screening tool and to
use them to streamline the screening process at all annual visits, should also be considered.
Implementing or creating a pre-made template built into the EHR system at the clinic for
providers to make their own template, may allow for a smoother and more efficient integration of
skin cancer risk screenings, as well. As mentioned previously, the research shows that although it
is proven that early detection in primary care improves outcomes for patients with malignant
melanoma, providers may not be properly screening their patients on their risk level, thus
missing patients at high-risk and providing them with proper education on how to keep
themselves safe.

Policy Recommendations
Although unlikely, the ideal policy recommendation would be for all cancer societies to
come together and agree on one recommendation when it comes to skin cancer screenings. A
more obtainable recommendation would be a policy change within each clinic where they decide
on one recommendation to follow and adopt this as standard practice, so all providers practice
the same way. Finally, Medicare does not currently cover annual skin exams, regardless of
patient risk (West, 2020). There is also no national quality metric attached to skin cancer
screenings endorsed by the Centers for Medicare and Medicaid Services. If this was a practice
that was measured and covered by insurance, there would be more incentive for PCPs to perform
skin cancer risk screenings and skin cancer screening on their patients.
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Research Recommendations
There are several research implications of this study. Identifying barriers and facilitators
of implementing the use of the SAMScore Questionnaire, or any other risk screening tool, into
the normal process by a provider at an annual visit will allow those barriers to be addressed, with
the hopes of achieving 100% screening rates. Further investigation of the type of education
provided to patients regarding skin protection and skin cancer prevention, as well as how the
education is being provided is also warranted. In this study providers were given instructions to
provide skin protection education to high-risk patients; it was not specified what education they
provided or how the education was provided. Evaluating whether reminders or prompts within
the EHR or physically placed around the clinic increase screening rates would also be interesting
for future research. Finally, conducting future research on subsequent care being provided among
those that have been classified as high-risk, such as a completed skin assessment or dermatology
referral, could identify additional opportunities for improvement.

Limitations
The project had many limitations related to sample size, design, and data collection. One
limitation was that only two of seven providers at this clinic participated in this project for
multiple reasons including only working part-time, being on vacation during the implementation
timeframe, personal choice etc. Because of this, there was a smaller number of patients that
could be included in the sample. According to providers at this practice, the population seen at
this clinic can be somewhat nonadherent when it comes to well visits and they have frequent “no
shows”. The limitations caused by COVID, such as fears of office visits related to potential
exposure, may have also hurt the number of patients that the providers were seeing for annual
exams, thus lowering the sample size for this project. Additionally, providers are seeing upwards
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of 20 patients per 8-hour day at this clinic and time per visit is always an issue. Providers already
have many points they need to screen and counsel patients about at annual visits, on top of
management of chronic issues. Because of this, providers may have chosen to spend their time
on other, more pertinent screening/counseling for a specific patient and the SAMscore
Questionnaire may have been lower on the list of priorities and for that reason, it may not have
been completed.

Conclusion
The recommendation by Memorial Sloan Kettering Cancer Center (2022), states that
individuals identified as high risk should be evaluated once a year for skin cancer assessment.
The USPSTF recommends behavioral counseling for skin protective behaviors for specific
populations at higher risk (HHS, 2016). As mentioned previously, the annual cost of treating skin
cancers in the U.S. is estimated at $8.1 billion (AAD, 2021). By educating on skin protection
behaviors, the U.S. could save an estimated $250 million a year in health care costs by
preventing an estimated 21,000 cases of melanoma by 2030 (CDC, 2021). Though data gathered
from this study indicates that the study was successful regarding using the SAMScore
Questionnaire to increase identification of high-risk patients, there is still room for improvement
when it comes to skin cancer risk screening and skin protection education in primary care, as less
than 60% of patients were screened. Further research should address barriers to screening and
continued efforts should be made to ensure our primary care providers are identifying those at
high risk to decrease unnecessary deaths and interventions and decrease cost to the health care
system.
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Tables
Table 1. Summary of Demographic of Patients Pre- and Post-Intervention
Pre (n = 30)
Post (n = 48)
Mean (SD) or n (%)
Mean (SD) or n (%)
Age

39.5 (13.3)

41.1 (13.5)

Sex
Male
Female

8 (26.7%)
22 (73.3%)

20 (41.7%)
28 (58.3%)

Race/ethnicity
Caucasian
African American
Hispanic/Latino

p

.62

.179

.99
23 (76.7%)
2 (6.7%)
5 (16.7%)

36 (75%)
4 (8.3%)
8 (16.7%)

* p < .05

Table 2. Summary of Screening Characteristics of Patients Pre- and Post-Intervention
Skin cancer risk
Pre (n = 30)
Post (n = 48)
p
screening
Mean (SD) or n (%)
Mean (SD) or n (%)
<.001
Yes
No

0 (0%)
30 (100%)

27 (56%)
21 (43.8%)

* p < .05

Table 3. Summary of Skin Protection Education Provided Based on Risk
Skin protection
Not High Risk (n = 34)
High Risk (n = 14)
education
Mean (SD) or n (%)
Mean (SD) or n (%)

Yes
No

13 (38%)
21 (62%)

34

14 (100%)
0 (0%)

Table 4. Summary of Differences in Screening by Demographics Post-Intervention
Screened (n = 27)
Not screened (n = 21)
p
Mean (SD) or n (%)
Mean (SD) or n (%)
Age

Sex
Male
Female

Race/ethnicity
Caucasian
African American
Hispanic/Latino

27 (14.6)

21 (11.9)

10 (50%)
17 (60.7%)

10 (50%)
11(39.3%)

.344

.329

.096
19 (52.8%)
1 (25%)
7 (87.5%)

17 (47.2%)
3 (75%)
1 (12.5%)

* p < .05
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Appendices
Appendix 1. Self-assessment of Melanoma Risk (SAMScore) Questionnaire
Answer each question by checking the appropriate square:
1. What skin type do you have?
• Skin-type I: very fair skin, blond or red hair, light eyes (blue or green), never tan
and always sunburn after sun exposure
• Skin-type II: fair skin, blond or light brown hair, light eyes (blue or green),
usually sunburn
• Skin-type III: dark skin, brown hair, light to medium eye color
• Skin-type IV: olive skin, dark brown hair, brown eyes
• Skin-type V: brown skin, black hair, black eyes
• Skin-type VI: black skin, black hair, black eyes
2. Do you have freckles?
• Yes
• No
3. How many moles do you approximately have on both arms?
• Fewer than 20
• More than 20
4. Have you had one or more episodes of severe blistering sunburn during childhood or
teenage years?
• Yes
• No
5. Did you live more than 1 year in a country where sunshine is high (Africa, French West
Indies, South of United States, Australia…)?
• Yes
• No
6. Have you been diagnosed with melanoma in the past?
• Yes
• No
7. Has any first-degree relatives (parents, siblings, children) ever had melanoma?
• Yes
• No
• Don’t know
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According to the SAMScore, a patient is considered at elevated risk for melanoma if at least one
of these three criteria is verified:
• First criterion: Presence of at least 3 risk factors (phototype I or ii, freckling tendency,
number of naevi >20 on both arms, sever sunburn during childhood or teenage years, life in a
country of low latitude, a history of pervious melanoma, a history of melanoma in a firstdegree relative)
• Second criterion: A subject under 60 years of age and a number of melanocytic naevi >20 on
both arms.
• Third criterion: A subject 60 years old or older with a freckling tendency.
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Appendix 2. Provider Education Outline
•

Description of project
o Background and problem statement
o Goals/Aims

•

Description of SAMScore Questionnaire
o Designed to determine whether a patient is at “normal” risk or "high” risk of
developing Melanoma in their lifetime
o Seven questions
o Completed by patient
o Validated, evidence-based tool

•

Educated on how to interpret results of SAMScore Questionnaire

•

Expectations from providers
o Implement use of SAMScore Questionnaire into standard workflow at annual
exams
o Provide to patients aged 18-64 who have never been diagnosed with skin cancer
o Provide skin protection education to patients identified as “high-risk”
o Document that SAMScore was provided
o Document patient risk
o Document whether skin protection education was provided
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Appendix 3. Chart Audit Tool
Unique
ID

Age

Gender

Race/Ethnic
ity

Received
skin cancer
risk
screening
Yes/No

1

39

High Risk?
Yes/No

Received
skin cancer
prevention
education
Yes/No

